本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viking Therapeutics, Inc.

31.63
+0.93003.03%
盤後31.710.0800+0.25%19:58 EDT
成交量:263.62萬
成交額:8,288.04萬
市值:35.52億
市盈率:-27.43
高:31.94
開:31.35
低:30.67
收:30.70
資料載入中...
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities